http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180045330-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9267640d5ff907acc84cfcd9bfed9232 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2523-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 |
| filingDate | 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c11c84ee75feea2543b1a4be7c0a01b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8430edb6028791b0702bf47f5bcaced7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f4e08971a12500ea5ee1aa0c1f3e89b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d988dc5dc36e1435f9713832b1b87bf |
| publicationDate | 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180045330-A |
| titleOfInvention | A medium compostion for regulatory T cells derived from peripheral blood mononuclear cells, and cultivation method using the same |
| abstract | The present invention relates to a culture medium for regulating T cell cultures derived from peripheral blood mononuclear cells and a method of culturing conditioned T cells using the same. More particularly, the present invention relates to a culture medium for culture of T cells, And the effect of promoting differentiation and mass proliferation of regulatory T cells in the composition was confirmed. In addition, it was confirmed that the regulated T cells proliferated by the method of the present invention can remarkably effectively inhibit the activity and proliferation of target immune cells. Accordingly, the present invention relates to a medium composition for afzelin-based culture and a method for culturing regulatory T cells using the same. Also, the peripheral blood mononuclear cell-regulated T cells cultured by the method according to the present invention can be used as a pharmaceutical composition highly effective in the treatment of autoimmune diseases. Further, the culture medium composition of the present invention can be used as such in the treatment of autoimmune diseases. |
| priorityDate | 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.